Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/33912
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.date.accessioned2023-09-20T06:40:07Z-
dc.date.available2023-09-20T06:40:07Z-
dc.date.issued2017-
dc.identifier.citationTekin, R. T. vd. (2017). ''The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey''. Human Vaccines and Immunotherapeutics, 13(5), 1182-1189.en_US
dc.identifier.issn2164-5515-
dc.identifier.issn2164-554X-
dc.identifier.urihttps://doi.org/10.1080/21645515.2016.1268304-
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/21645515.2016.1268304-
dc.identifier.urihttp://hdl.handle.net/11452/33912-
dc.descriptionÇalışmada 24 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır.tr_TR
dc.description.abstractThe serogroup epidemiology of invasive meningococcal disease (IMD), which varies considerably by geographic region and immunization schedule, changes continuously. Meningococcal carriage data are crucial for assessing IMD epidemiology and designing f potential vaccination strategies. Meningococcal seroepidemiology in Turkey differs from that in other countries: serogroups W and B are the predominant strains for IMD during childhood, whereas no serogroup C cases were identified over the last 10 y and no adolescent peak for IMD was found. There is a lack of data on meningococcal carriage that represents the whole population. The aims of this multicenter study (12 cities in Turkey) were to evaluate the prevalence of Neisseria meningitidis carriage, the serogroup distribution and the related risk factors (educational status, living in a dormitory or student house, being a household contact with Hajj pilgrims, smoking, completion of military service, attending bars/clubs) in 1518 adolescents and young adults aged 10-24 y. The presence of N. meningitidis DNA was tested, and a serogroup analysis was performed using polymerase chain reaction. The overall meningococcal carriage rate was 6.3% (n = 96) in the study population. A serogroup distribution of the 96 N. meningitidis strains isolated from the nasopharyngeal specimens revealed serogroup A in 5 specimens (5.2%), serogroup B in 9 specimens (9.4%), serogroup W in 64 specimens (66.6%), and serogroup Y in 4 specimens (4.2%); 14 were classified as non-grouped (14.4%). No serogroup C cases were detected. The nasopharyngeal meningococcal carriage rate was 5% in the 10-14 age group, 6.4% in the 15-17 age-group, and 4.7% in the 18-20 age group; the highest carriage rate was found in the 21-24 age group (9.1%), which was significantly higher than those of the other age groups (p < 0.05). The highest carriage rate was found in 17-year-old adolescents (11%). The carriage rate was higher among the participants who had had close contact with Hajj/Umrah pilgrims (p < 0.01) or a history of upper respiratory tract infections over the past 3 months (p < 0.05). The nasopharyngeal carriage rate was 6.3% among adolescents and young adults in Turkey and was similar to the recent rates observed in the same age groups in other countries. The most prevalent serogroup was W, and no serogroup C cases were found. In conclusion, the present study found that meningococcal carriage reaches its peak level by age 17, the highest carriage rate was found in 21-to 24-year-olds and the majority of the carriage cases were due to serogroup W. Adolescents and young adult carriers seem to be a potential reservoir for the disease, and further immunization strategies, including adolescent immunization, may play a role in the control of IMD.en_US
dc.description.sponsorshipEskişehir Osmangazi Üniversitesi Bilimsel Araştırma Projeleri - 2014/455tr_TR
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBiotechnology & applied microbiologyen_US
dc.subjectImmunologyen_US
dc.subjectNeisseria-meningitidis carriageen_US
dc.subjectStreptococcus-pneumoniaeen_US
dc.subjectNasopharyngeal carriageen_US
dc.subjectPharyngeal carriageen_US
dc.subjectHajj pilgrimsen_US
dc.subjectDiseasecen_US
dc.subjectHildrenen_US
dc.subjectOutbreaken_US
dc.subjectW135en_US
dc.subjectStrainen_US
dc.subject.meshAdolescenten_US
dc.subject.meshCarrier stateen_US
dc.subject.meshChilden_US
dc.subject.meshDNA, bacterialen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMeningococcal infectionsen_US
dc.subject.meshNasopharynxen_US
dc.subject.meshNeisseria meningitidisen_US
dc.subject.meshPolymerase chain reactionen_US
dc.subject.meshPrevalenceen_US
dc.subject.meshRisk factorsen_US
dc.subject.meshSeroepidemiologic studiesen_US
dc.subject.meshSerogroupen_US
dc.subject.meshTurkeyen_US
dc.subject.meshVaccinationen_US
dc.subject.meshYoung adulten_US
dc.titleThe prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkeyen_US
dc.typeArticleen_US
dc.identifier.wos000401516100041tr_TR
dc.identifier.scopus2-s2.0-85019603921tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.tr_TR
dc.identifier.startpage13tr_TR
dc.identifier.endpage5tr_TR
dc.identifier.volume1182tr_TR
dc.identifier.issue1189tr_TR
dc.relation.journalHuman Vaccines and Immunotherapeuticsen_US
dc.contributor.buuauthorHacımustafaoğlu, Mustafa-
dc.contributor.researcheridCTG-5805-2022tr_TR
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed28140784tr_TR
dc.subject.wosBiotechnology & applied microbiologyen_US
dc.subject.wosImmunologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid6602154166tr_TR
dc.subject.scopusMeningococcosis; Serotype; Neisseria Meningitidisen_US
dc.subject.emtreeBacterial DNAen_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAge distributionen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeDisease carrieren_US
dc.subject.emtreeDNA extractionen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHouseholden_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMeningitisen_US
dc.subject.emtreeMilitary servicetr_TR
dc.subject.emtreeNasopharyngeal swaben_US
dc.subject.emtreeNeisseria meningitidisen_US
dc.subject.emtreeNose smearen_US
dc.subject.emtreePolymerase chain reactionen_US
dc.subject.emtreePrevalenceen_US
dc.subject.emtreeQuestionnaireen_US
dc.subject.emtreeReligionen_US
dc.subject.emtreeRisk factoren_US
dc.subject.emtreeSmokingen_US
dc.subject.emtreeSocioeconomicsen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeUpper respiratory tract infectionen_US
dc.subject.emtreeYoung adulten_US
dc.subject.emtreeClassificationen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeGeneticsen_US
dc.subject.emtreeHeterozygoteen_US
dc.subject.emtreeImmunologyen_US
dc.subject.emtreeIsolation and purificationen_US
dc.subject.emtreeMeningococcosisen_US
dc.subject.emtreeMicrobiologyen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreeNasopharynxen_US
dc.subject.emtreeNeisseria meningitidisen_US
dc.subject.emtreeSeroepidemiologyen_US
dc.subject.emtreeSerotypeen_US
dc.subject.emtreeVaccinationen_US
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Dosya Açıklama BoyutBiçim 
Hacımustafaoğlu_vd_2017.pdf1.2 MBAdobe PDFKüçük resim
Göster/Aç


Bu öğe kapsamında lisanslı Creative Commons License Creative Commons